Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 2, 1996, Pages 290-299

  Stone, Jonathan ^b   Chan Ling, Tailoi ^b   Pe'er, Jacob ^a   Itin, Ahuva ^a   Gnessin, Hadassah ^a   Keshet, Eli ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

astrocytes; retinal development; retinal vasculature; retinopathy of prematurity; vascular endothelial growth factor (VEGF)

Indexed keywords

OXYGEN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CAT; CONTROLLED STUDY; GROWTH INHIBITION; HYPEROXIA; IMMUNOPATHOGENESIS; NONHUMAN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RETINA DEGENERATION; RETINOPATHY; RETROLENTAL FIBROPLASIA; VASCULAR ENDOTHELIUM;

ANIMALS; ASTROCYTES; CATS; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPEROXIA; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INFANT, NEWBORN; LYMPHOKINES; OXYGEN INHALATION THERAPY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030044257     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: A clinical approach. Med J Austr. 1951;48-50.
2. Patz A. Oxygen studies in retrolental fibroplasia: V: The effect of rapid vs gradual withdrawal from oxygen on the mouse eye. Arch Ophthalmol. 1957;57:727-729.
3. Ashton NA. Experimental retrolental fibroplasia. Ann Rev Med. 1957;8:441-454.
4. Ashton N. Oxygen and the growth and development of retinal vessels. Am J Ophthalmol. 1966;62:412-435.
5. Ashton N. Pathological basis of retrolental fibroplasia. Br J Ophthalmol. 1954;38:385-396.
6. Ashton N, Ward B, Serpell G. Role of oxygen in the genesis of retrolental fibroplasia. Br J Ophthalmol. 1953;37:513-520.
7. Chan-Ling T, Tout S, Holländer H, Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992;33:2128-2147.
8. Chan-Ling T, Stone J. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci. 1992;33:2148-2159.
9. Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division: Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci. 1995;36:120-1214.
10. Chan-Ling T, Gock B, Stone J. Supplemental oxygen therapy: Basis for noninvasive treatment of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1995;36:1215-1230.
11. Stone J, Itin A, Alon T, Gnessin H, Chan-Ling T, Pe'er Y, Keshet E. Development, of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
12. Chan-Ling T, Stone J. Retinopathy of prematurity: Its origins in the architecture of the retina. Prog Retinal Res. 1993;12:155-178.
13. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
14. Millauer B, Wizigmann-Voos S, Schnürch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835-846.
15. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677-1683.
16. Chan-Ling T, Halasz P, Stone J. Development of retinal vasculature in the cat: Processes and mechanisms. Curr Eye Res. 1990;9:459-478.
17. Chan-Ling T, Stone J. The development of astrocytes in the cat retina: Evidence of migration from the optic nerve. Dev Brain Res. 1988;44:73-85.
18. Holländer H, Makarov F, Dreher Z, van Driel D, Chan-Ling T, Stone J. Functions of the macroglia of the retina: The sharing and division of labour between astrocytes and Müller cells. J Comp Neurol. 1991; 313:587-603.
19. Stone J, Dreher Z. Relationship between astrocytes, ganglion cells and vasculature of the retina. J Comp Neurol. 1987;255:35-49.
20. Chan-Ling T, Stone J. Factors determining the migration of astrocytes into the developing retina: Migration does not depend on intact axons or patent vessels, J Comp Neurol. 1991;303:375-386.
21. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987;325:253-257.
22. Tout S, Chan-Ling T, Holländer H, Stone J. The role of Müller cells in the formation of the blood retinal barrier. Neuroscience. 1993;55:291-301.
23. Pierce EA, Avery RT, Foley ED, Aiello LP, Smith L. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularisation. Proc Natl Acad Sci USA. 1995; 92:905-909.
24. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994; 145:574-584.
25. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.